lorazepam has been researched along with Dyslipidemias in 1 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsiakitzis, KC | 1 |
| Rekka, EA | 1 |
| Kourounakis, AP | 1 |
| Kourounakis, PN | 1 |
1 other study available for lorazepam and Dyslipidemias
| Article | Year |
|---|---|
Novel compounds designed as antistress agents.
Topics: Amides; Animals; Anti-Anxiety Agents; Antioxidants; Benzoates; Brain; Carboxylic Acids; Chromans; Dr | 2009 |